ALF Academic Debates (@AlfDebates) header
ALF Academic Debates (@AlfDebates) profile picture
Joined February 2018
Photo by ALF Academic Debates (@AlfDebates)Photo by ALF Academic Debates (@AlfDebates)Photo by ALF Academic Debates (@AlfDebates)Photo by ALF Academic Debates (@AlfDebates)
Thank you to our Participating Advocates: Alexion, Dova, Northwestern, and FUJIFILM Wako
1
Thank you to our Judges, Dr. Nikhil Bhargava, Dr. Sheila Eswaran, and Dr. Rocky Yapp
1
Thank you to Loyola Medicine Mentor, Dr. Jamie Berkes, and Fellows, Dr. Laura Nunez-Herrero and Dr. Irfan Rahman
3
Thank you to University of Illinois Mentor, Dr. Adam Mikolajczyk and Fellows, Dr. Wasseem Skef and Dr. Mitali Agarwal
1
2
Loyola Medicine will argue that TARE should be the primary locoregional therapy for unresectable HCC
2
The University of Illinois will argue, TACE should be the primary locoregional therapy for unresectable HCC
1
2
The final debate tonight asks, is TACE or TARE prefearble in patients with unresectable HCC?
3
Thank you to our Partner Advocates: Bayer, CVS, Eisai, Novartis, & Salix
1
Thank you to the Cook County Fellows, Dr. Alexander Nguyen & Dr. Efe Aisien
1
Thank you to the Cook County Mentor, Dr. Bashar Attar
1
Thank you you to the University of Iowa fellows, Dr. James Vancura & Dr. Jagpal Klair
1
That you to the University of Iowa mentor Dr. Arvind Murali
1
Cook County Health will argue the Con position that all patients with immune tolerant HBV do not need to be treated
1
University of Iowa will argue that all patients with immune tolerant HBV should be treated
The Hepatitis Topic is, "Should patients with immune tolerant Hepatitis B be treated?"
Thank You to our Premier Advocates: Abbvie, Gilead, and Intercept
Thank you to the University of Chicago Fellows: Dr. Jennifer Wang & Dr. Parita Patel
1
Thank you to University of Chicago's Mentor, Dr. Anjana Pillai
1
Thank you to Northwestern Medicine's Mentor, Dr. Priya Maddur
Thank you to the Northwestern Medicine Fellows: Dr. Alex Lemmer & Dr. Hersh Shroff